Carlyle Group Inc.
WASHINGTON, DC · CIK 1527166 · 13F filing filed 2026-08-07
SEC-registered investment adviser since 1996 · limited liability company
- Assets managed$283.8bn
- Staff1,040 · 317 in investment roles
- Main clients (by assets)Private funds 72%, Insurers 28%
- Private funds314 (1 hedge) · $173.6bn gross assets
- Form ADV · 2026-07-07SEC adviser record
- Legal entityTHE CARLYLE GROUP INC. (US)
Other 13F filers in this group: AlpInvest Partners B.V. $59.9m, Abingworth LLP files a notice, Carlyle Investment Management LLC files a notice
This report includes the holdings of 3 other managers that share the investment decisions:
- Abingworth LLP – reports through this filing
- CIM Global, L.L.C. – reports through this filing
- Carlyle Investment Management LLC – reports through this filing
Also in the report of:
- AlpInvest Partners B.V. – $3.7m of shares are in both reports
- TCW GROUP INC
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MEDLINE INC MDLN | $7.4bn73.78% | Unchanged |
| STANDARDAERO INC SARO | $2.5bn25.30% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $37.9m0.38% | Unchanged |
| INVITATION HOMES INC INVH | $20.0m0.20% | Reduced -1.2k |
| PONY AI INC PONY | $16.4m0.16% | Unchanged |
| GETTY IMAGES HOLDINGS INC GETYQ | $5.4m0.05% | Unchanged |
| SPRUCE BIOSCIENCES INC SPRB | $2.1m0.02% | Unchanged |
| SUNPOWER INC SPWR | $1.6m0.02% | Added +1.9m |
| ADICET BIO INC ACET | $1.6m0.02% | Unchanged |
| FORWARD AIR CORP FWRD | $1.4m0.01% | Unchanged |
| ONKURE THERAPEUTICS INC OKUR | $1.2m0.01% | Unchanged |
| KRISPY KREME INC DNUT | $1.2m0.01% | Unchanged |
| Q32 BIO INC QTTB | $769.0k0.01% | Reduced -1.0m |
| RILEY EXPLORATION PERMIAN IN REPX | $530.4k0.01% | New |
| NEBIUS GROUP N.V. NBIS | $509.8k0.01% | New |
| ROBINHOOD MKTS INC HOOD | $474.6k0.00% | Added +1.4k |
| JASPER THERAPEUTICS INC JSPR | $448.9k0.00% | Unchanged |
| N-ABLE INC NABL | $344.0k0.00% | Unchanged |
| RAMACO RES INC METC | $287.7k0.00% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| CUBESMART CUBE | $8.1m220.5k shares |
| HEARTFLOW INC HTFL | $497.3k20.4k shares |
| SPYRE THERAPEUTICS INC SYRE | $485.2k9.6k shares |
| EXICURE INC XCUR | $239.6k56.3k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| STANDARDAERO INC SARO · 13G · filed 2026-05-15 | 25.4%≈ $2.5bn |
| MEDLINE INC MDLN · 13G · filed 2026-05-15 | 20.6%≈ $7.4bn |
| COMMSCOPE HLDG CO INC VISN · 13D · filed 2025-08-05 | 17.5%≈ $567.4m |